Lynthera Corporation Profile last edited on: 2/9/2024
CAGE: 79RQ5
UEI: EHB9K3ECWV79
Business Identifier: Novel therapy to improve treatment of eye disease. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 11
County: Lancaster
Congr. District: 11
County: Lancaster
Public Profile
A technology company structured around research into novel therapy(ies) to improve the treatment of eye disease, Lynthera has developed a Drug Delivery Contact Lens (DDCL) structured around the use of nanotechnology to deliver topical eye drops. Offfering significant advantages over currently available systems, the primary focus at this juncture is development of the approach to treat glaucoma. If determined to be effective, the platform has the potential to create a new paradigm of drug delivery that could transform the broader field of eye care.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2024 | 2 | NIH | $1,200,003 | |
| Project Title: Drug delivery platform for ocular allergy therapy | ||||
| 2023 | 1 | NIH | $375,000 | |
| Project Title: Novel formulation technology for the sustained release naloxone to improve outcomes in the management of opioid overdose | ||||
| 2023 | 2 | NIH | $1,890,000 | |
| Project Title: Sustained delivery technology for Cyclosporine a in the treatment of autoimmune response | ||||
Key People / Management
Jeff Yang -- Co-Founder, President & Chief Executive Officer
Roman Domszy -- Senior Research Scientist
Cesar Torres Luna -- Research Scientist
Arthur Yang
Roman Domszy -- Senior Research Scientist
Cesar Torres Luna -- Research Scientist
Arthur Yang
Company News
There are no news available.
